bpc 157 hims & Hers shares are trading higher after an FDA advisory panel recommended adding BPC-157 to the 503A compounding list, potentially widening access through licensed pharmacies HIMS FDA PANEL VOTES 'YES'

HIMS FDA PANEL VOTES 'YES' ON BPC 157 THE 8 PCAC PANELIST MEMBERS WHO VOTED YES: 1. Asare Christian 2. David Pope 3. Gabriel Alizaidy 4. Haleem Mohammed 5. Joshua Starbuck 6. Kris Wusterhausen 7. Melissa Loseke 8. Bobby Harshbarger BPC 157 Wholesale Pricing HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer HIMS THE VOTE FOR BPC 157 HAPPENS AT 11:45 A.M. ET BPC 157 PURE Immediate Release Heart + Sol

SKU: 40363207221 · From aimoneimmobiliare.it